Home/AI Tools/Syngens

Syngens

AI-driven gene synthesis platform.
General Information
Founded Date:
2020-11-01
Headquarters Region:
Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA)
Domain Rating:
3.3
Last Equity Funding Date:
2024-06-12
Last Equity Funding Type:
Non-equity Assistance

Overview

Syngens.ai is an AI-powered tool that revolutionizes gene synthesis and bioinformatics for researchers and biotech professionals.

Key Features

Gene synthesis, bioinformatics analysis, sequence optimization, data management.

Pros

High accuracy in synthesis, robust bioinformatics tools, user-friendly interface.

Cons

Limited integration options with third-party tools, requires internet access.

bg

Get Exclusive Content
Straight to Your Inbox

Subscribe to our [A] Growth Newsletter

More AI tools like this